An interventional study of swept-source optical coherence tomography in Schlemm's Canal Occlusion, sponsored by Wenzhou Medical University. Completed at 1 site in China. Open to participants aged 7 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-04-24.
Sponsored by Wenzhou Medical University · Not applicable, Interventional, and Prevention
The aim of this study is to quantify and observe the morphology of trabecular meshwork (TM), Schlemm's canal (SC), ciliary body and crystalline lens before and after cycloplegia in patients with different ages using swept-source optical coherence tomography.
Wenzhou Medical University is the lead sponsor of 93 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Swept-source optical coherence tomography A device testing TM/SC and Lens morphology
Device: swept-source optical coherence tomography
Aswe pt-source OCT (CASIA SS-1000; Tomey Corporation, Nagoya, Japan), which is specifically designed for anterior segment imaging using a 1310 nm wavelength with a scan speed of 30,000 A-scans per second and an axial resolution of \<10 μm.
area of Schlemm's canal and trabecular meshwork
The area of Schlemm's canal and trabecular meshwork was manually measured and the relationship between the parameters and age was analyzed.
Time frame: up to 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Wenzhou Medical University